Skip to main content

Table 3 COX regression analysis of risk factors in patients with high-grade serous ovarian carcinoma

From: Biological and prognostic value of ETV5 in high-grade serous ovarian cancer

  Univariate analysis Multivariate analysis
  HR (95%CI) P value HR (95%CI) P value
ETV5 expression (low- vs over-expression) 2.108(1.190–3.736) 0.011* 1.427(0.485–4.192) 0.518
Age (<55 vs ≥ 55) 0.534(0.322–0.885) 0.015* 0.713(0.379–1.340) 0.293
FIGO stage (I-IIvsIII-IV) 9.626(3.722–24.899) ≤0.001*** 5.301(1.564–1.973) 0.007**
Recurrence (no vs yes) 2.542(1.178–5.482) 0.017* 2.670(1.140–6.253) 0.024*
Chemotherapy response (sensitive vs partial) 0.967(0.520–1.798) 0.915   
Ascites (no vs yes) 1.192(0.562–2.527) 0.647